Latest research in Hodgkin lymphoma
Athough new molecules have advanced the treatment of Hodgkin lymphoma considerably in recent years, research is still ongoing to achieve the best possible outcomes for patients. Speaking from the Amer...
Author: VJHemOnc
Added: 12/15/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 15, 2017 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy discussions at ASH 2017
Immunotherapy has been a primary area of focus in lymphoma research in recent years, with treatments looking to stimulate and bolster the patients immune system to figh cancer. In this interview, Rau...
Author: VJHemOnc
Added: 12/15/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 15, 2017 Category: Cancer & Oncology Source Type: podcasts
Key Insights: Lymphoma & amp; Myeloma 2017 - CLL
In this activity, Congress Chair Dr. Morton Coleman and CLL Session Co-Chair Dr. Richard R. Furman discuss highlights of the second day of Lymphoma & Myeloma 2017: An International Congress on Hem...
Author: imedex
Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts
Key Insights: Lymphoma & Myeloma 2017 - Lymphoma
In this Key Insights activity, Congress Chair Dr. Morton Coleman and Lymphoma Session Co-Chair Dr. John Leonard discuss highlights of the third day of Lymphoma & Myeloma 2017: An International Congre...
Author: imedex
Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts
Key Insights: Lymphoma & Myeloma 2017 - Multiple Myeloma
In this Key Insights activity, Drs. Morton Coleman and Ruben Niesvizky discuss highlights of the first day of Lymphoma & Myeloma 2017: An International Congress on Hematologic Malignancies held in Oc...
Author: imedex
Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts
Making cancer treatments more affordable
Steven T. Rosen, MD, from the City of Hope, Duarte, CA, discusses the affordability of cancer treatments at the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada. Th...
Author: VJHemOnc
Added: 11/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 21, 2017 Category: Cancer & Oncology Source Type: podcasts
Repurposed HIV and arthritis drugs in the treatment of leukaemia
Steven T. Rosen, MD, from the City of Hope, Duarte, CA, discusses novel conceptual treatment approaches at the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada. A n...
Author: VJHemOnc
Added: 11/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 21, 2017 Category: Cancer & Oncology Source Type: podcasts
The evolution of CAR T-cell therapy
Steven T. Rosen, MD, from the City of Hope, Duarte, CA, discusses the evolution of CAR T-cell therapy at the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada. CAR T...
Author: VJHemOnc
Added: 11/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 21, 2017 Category: Cancer & Oncology Source Type: podcasts
BTK inhibitors: toxicity, resistance, and combinations
Steven T. Rosen, MD, from the City of Hope, Duarte, CA, discusses recent developments in BTK inhibitors at the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada. BTK...
Author: VJHemOnc
Added: 11/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 21, 2017 Category: Cancer & Oncology Source Type: podcasts
Exciting advances in checkpoint inhibitors CAR T-cells, and ALK inhibitors
Steven T. Rosen, MD, from the City of Hope, Duarte, CA, discusses highlights of the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada. More concrete data had been re...
Author: VJHemOnc
Added: 11/20/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 20, 2017 Category: Cancer & Oncology Source Type: podcasts
Describing clonal evolution in lymphoma
Michael Pfreundschuh, MD from the Saarland University, Homburg, Germany is joined by Ryan Morin, PhD from the BC Cancer Agency, Vancouver, Canada, Reiner Siebert, MD from the Institute of Human Geneti...
Author: VJHemOnc
Added: 11/20/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 20, 2017 Category: Cancer & Oncology Source Type: podcasts
The role of epigenetic modulators in the pathogenesis of lymphomas
Anas Younes, MD, from the Memorial Sloan Kettering Cancer Center, New York, NY is joined by Eduardo Sotomayor, MD, from the George Washington University School of Medicine & Health Sciences, Washi...
Author: VJHemOnc
Added: 11/20/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 20, 2017 Category: Cancer & Oncology Source Type: podcasts
How are immunotherapies re-shaping the treatment of lymphoma
Catherine Bollard, MBChB, MD, FRACP, FRCPA from the Childrens National Health System and the George Washington University, Washington, D.C. chairs a lively discussion on the fast-evolving field of im...
Author: VJHemOnc
Added: 11/20/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 20, 2017 Category: Cancer & Oncology Source Type: podcasts
Side effects of novel PI3K inhibitors
Nathan Fowler, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, discusses side effects of PI3K inhibitors at the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in ...
Author: VJHemOnc
Added: 11/17/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 17, 2017 Category: Cancer & Oncology Source Type: podcasts
